|Dr. Javier S. Burgos Ph.D.||Chief Exec. Officer||N/A||N/A||N/A|
|Dr. Antonio Sánchez Torres||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Soraya Santana Martínez||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. James Webb||Chief Commercial Officer||N/A||N/A||N/A|
|Mr. Enrique Lahuerta Traver||Sec.||N/A||N/A||N/A|
Neuron Bio, S.A. operates as a biotechnological company in Spain. It operates through Pharma, Diagnostic, and Services divisions. The Pharma division offers preventative drugs and treatments for neurodegenerative diseases primarily for Alzheimers disease. The diagnostic division develops tools and biomarkers for the diagnosis of central nervous system diseases. The Services division provides a range of research and development services in the fields of biomedicine, toxicology, and agri-food. The company was founded in 2005 and is headquartered in Granada, Spain.
El ISS Governance QualityScore de Neuron Bio, S.A., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.